CDSCO Directs For E-Submission Of Applications For Veterinary Vaccines

Mumbai : In order to streamline the regulatory submission procedure, the Central Drugs Standard Control Organisation (CDSCO) has directed all State Licensing Authorities (SLAs) and manufacturers for online submission of applications for issuance of Form 41 (Registration Certificate) and Form 10 (Import License) for veterinary vaccines through Sugam portal.

The applicants seeking for such certificates/license may now apply through online Sugam portal as per the checklist in the developed modules. The facility of offline submission of applications in hard copy may not be available after March 25, 2021 for processing, according to a CDSCO notice.

Sugam is an e-Governance system to discharge various functions performed by CDSCO under Drugs and Cosmetics (D&C) Act, 1940. The software system developed is an online web portal where applicants can apply for NOCs, licenses, registration certificates, permissions and approvals.

It provides an online interface for applicants to track their applications, respond to queries and download the permissions issued by CDSCO. It also enables CDSCO officials to process the applications online and generate the permissions online and generate MIS reports.

It contains step-by-step guidance to the applicants of the Sugam portal with screenshots of the workflow for various application submissions.

Following sections which are detailed in Sugam are user registration and login, applicant dashboard, managing sub login accounts, form submission for various processes and post approval changes.

Applications were made in hard copy dossier format to various divisions in CDSCO before the Sugam portal was introduced. The timelines for granting permissions or approvals for applications were almost three times more than what is there in the current scenario.

Earlier the fees for applications were made in the respective bank and then the copy of challan/receipt was submitted to CDSCO office. But now in Sugam portal, fee is calculated according to the applications and can be paid online on the same portal in bharatkosh.gov.in. The receipt for payment is available on the portal which can be downloaded and submitted in the application.

Due to the introduction of the Sugam portal, India is now in the state to compete with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) regions.

[pdf-embedder url=”https://medicarepharmabusiness.com/wp-content/uploads/2021/03/online-application-form-41-form-10-090321080927.pdf” title=”online application form 41 form 10-090321080927″]

  • Related Posts

    DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

    New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

    India’s drug body flags 90 unapproved FDC medicines, states told to take action

    The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

    DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

    India’s drug body flags 90 unapproved FDC medicines, states told to take action

    India’s drug body flags 90 unapproved FDC medicines, states told to take action

    India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

    India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

    Unapproved drops for dry eyes pose risks: Govt

    Unapproved drops for dry eyes pose risks: Govt

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward